Genmab H-1B Visa Sponsorship 2026
Pharma & biotech Β· H-1B sponsor Β· FY2017β2026
π’ Plainsboro, NJ HQπ genmab.com
Does Genmab sponsor H-1B visas and green cards?
Yes. Genmab has filed 40 H-1B LCAs and 3 PERM green-card cases with the U.S. Department of Labor between FY2020 and FY2026. In FY2025β2026 Genmab filed 18 H-1B LCAs at a median base salary of $192,201, about 58% above the national H-1B median of $121,966 for the same period. 2 green-card cases were decided in FY2024.
Its H-1B filings climbed 44% from FY2024 to FY2025 (9 β 13).
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 5 | $165k |
| FY2025 | 13 | $205k |
| FY2024 | 9 | $175k |
| FY2023 | 6 | $188k |
| FY2022 | 3 | $170k |
| FY2021 | 3 | $146k |
| FY2020 | 1 | $231k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Associate Director, Global Drug Safety and Pharmacovigilance2$165k
- 2Director, Clinical Research Scientist2$208k
- 3Principal Tech Lead, SAP App Development, Enabling Functions2$205k
- 4Assoc Dir, Global Drug Safety & Pharmacovgilance Physician1$219k
- 5Assoc. Dir. Global Drug Safety & Pharmacovigilance Scientist1$170k
- 6Associate Corporate Counsel1$155k
- 7Associate Director, Commercial Data Engineering1$230k
- 8Associate Director, Commercial Data Science1$195k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year β
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2024 | 2 | $193k |
| FY2023 | 1 | $237k |
Green-card route and outcomes
Worker backgrounds Β· FY2017β2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 118
- US patents
- Published, not yet granted
- 293
- applications
- Most recent grant
- April 7, 2026
- Top area
- Peptides100
Pay against the local market
Genmabβs most-filed occupations and metros, FY2021βFY2024. Its median base salary is 116% of the local BLS median for the same work.
| Occupation | Metro | Filings | Genmab pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Natural Sciences Managers | New York, NY | 2 | $199,487 | $174,650 | 114% |
| Software Developers | Trenton, NJ | 1 | $124,301 | $118,703 | 105% |
| Managers, All Other | Boston, MA | 1 | $230,000 | $174,840 | 132% |
About Genmab
Genmab is a pharma & biotech company based in Copenhagen, Denmark. It was founded in 1998 and has about 1,800 employees worldwide. It is listed on Nasdaq Copenhagen A/S as GEN.
- Name (DOL filings)
- Genmab
- Listed
- Nasdaq Copenhagen A/S: GEN
- Sponsoring since
- FY2020
- Headquarters
- Copenhagen, Denmark
- Industry
- Pharma & biotech
- Employees (US, est)
- 1,067 (2024)
- H-1B filings
- 40
- Median base
- $183,000
- Founded
- 1998
Genmab pays a median H-1B base of $183,000 across FY2017β2026, about 70% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Genmab
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Replimune | 55 | 22 | $158k | 4 | 50% |
| Sangamo Therapeutics | 55 | 2 | $144k | 0 | β |
| Synthego | 53 | 3 | $105k | 3 | β |
| Genmab | 40 | 18 | $192k | 1 | β |
| Entrada Therapeutics | 40 | 13 | $130k | 6 | β |
| Seres Therapeutics | 40 | 5 | $106k | 0 | β |
| iota Biosciences | 40 | 5 | $197k | 3 | β |
